Showing results (1261-1270 of 1,380) with videos related to

Sort By:
Pageof 138
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2007
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humansMingxin Qian, Stephen A Bai, Bernice Brogdon, et al.
The Journal of Allergy and Clinical Immunology|May 31, 2019
Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohortJennifer A Namazy, Lucie Blais, Elizabeth B Andrews, et al.
Nature Plants|September 26, 2018
Molecular basis of flowering under natural long-day conditions in ArabidopsisYoung Hun Song, Akane Kubota, Michael S Kwon, et al.
Transfusion|May 1, 2024
Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell diseaseMarianne E M Yee, Mischa L Covington, Patricia E Zerra, et al.
Pediatrics|February 24, 2017
The Sudden Death in the Young Case Registry: Collaborating to Understand and Reduce MortalityKristin M Burns, Lauren Bienemann, Lena Camperlengo, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitorsXiao-Tao Chen, Bahman Ghavimi, Ronald L Corbett, et al.
Infection|February 1, 2024
Epidemiology and treatment of invasive Bartonella spp. infections in the United StatesMorgan Pizzuti, Pamela Bailey, Caroline Derrick, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Potent and selective aggrecanase inhibitors containing cyclic P1 substituentsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Kidney International|March 26, 2019
The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritisMichael P Madaio, Istvan Czikora, Nino Kvirkvelia, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimizationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Pageof 138